BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Leukemia & Lymphoma Society | Discovery Grant Program
DTSTART;VALUE=DATE:20250707
DTSTAMP:20260312T110514Z
UID:eb123791106f557151bd60512fadb167e9b6a9b4af5125b85927630d
CATEGORIES:Call for proposal
DESCRIPTION:Aim:  The Leukemia & Lymphoma Society\, Inc. (LLS) is a natio
 nal voluntary health agency dedicated to the conquest of hematologic malig
 nancies and relevant premalignant conditions.   The Discovery Grant Prog
 ram is a research award program designed to encourage basic research\, tec
 hnological innovation\, and informatics pipeline development.\n\nExamples 
 of projects of potential interest include:\n\n	cellular activities that un
 derlie the behavior and vulnerabilities of blood cancer cells including ph
 enomena or processes such as clonal evolution\, autophagy\, unique metabol
 ic vulnerabilities\, inflammation/inflammasomes\, DNA damage responses\, o
 rganellar changes\, and poorly understood cellular regulatory mechanisms\n
 	resistance mechanisms including immune evasion\, resistant clone evolutio
 n\, and cellular changes underlying development of resistance to chemother
 apies\n	novel biomarkers or techniques to detect and monitor blood cancer 
 development and progression\n	blood cancer cell interactions with the micr
 oenvironment and with the immune system\, including exploration of novel i
 mmune synapses\n\n\nFunding:       $750\,000\n\nDuration:      3
  years\n\nEligibility:    The program welcomes applications from US citi
 zens and non-US citizens\, as well as applicants who are performing resear
 ch outside the United States. Applicants must hold a PhD\, MD\, DVM\, or e
 quivalent degree. Applicants must be independent investigators affiliated 
 with a non-profit institution at the time funding commences and for the du
 ration of the award. Further\, they must be established investigators\, de
 fined as having more than 3 years in an independent faculty appointment at
  the time of the Letter of Intent.\n\nHow to Apply: The 2-stage applicatio
 n process begins with a Letter of Intent\, to be submitted on the LLS Rese
 arch Portal. LOIs should provide brief descriptions of how the goals and/o
 r approaches are novel and innovative\, and what impact the research may h
 ave on blood cancer. All LOIs will be reviewed\, and those judged to be th
 e most promising\, competitive\, and responsive to the goals of the progra
 m will be invited to submit a full application.  At the full application 
 stage\, an Institutional signature is required\; please contact the Resear
 ch Office for this step. Applicants will be notified of the final outcomes
  by June 2024.\n\nDeadline:    \n\n\n	Letter of Intent – 19 August 2
 025 (3PM ET)\n	Full Application – 19 November 2025 (3PM ET)\n\nFurther i
 nformation\n\n\n	More information about the program\, guidelines\, and ins
 tructions are available here\n	The application portal can be found here\n	
 For any other questions\, please contact the Research Office\n
LOCATION:
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR